Results 141 to 150 of about 3,787 (192)
Some of the next articles are maybe not open access.

Prokinetic agents in the surgical patient

The American Journal of Surgery, 1999
Surgeons may be confronted by several conditions that benefit from therapy with prokinetic agents. Prokinetic agents enhance contractile force, coordinate contractile activity, and accelerate transit in the gastrointestinal tract. Although some of these drugs may also have antiemetic effects, these are not the focus of this review.
J S, Thompson, E M, Quigley
openaire   +2 more sources

Prokinetics Influence the Pharmacokinetics of Rabeprazole

Digestion, 2008
<i>Background:</i> Proton pump inhibitors (PPIs) are unstable at a low PH. Accelerated transfer of PPIs to the upper small intestine may influence the pharmacokinetics of PPIs. <i>Aim:</i> To see if concomitant use of mosapride citrate with rabeprazole sodium influences the pharmacokinetics of the PPI. <i>Methods:</i>
Katsuhito, Arai   +5 more
openaire   +2 more sources

Cisapride: A Gastrointestinal Prokinetic Drug

Annals of Pharmacotherapy, 1994
OBJECTIVE: To summarize the pharmacology, pharmacokinetics, efficacy, and safety of cisapride, and to evaluate its potential therapeutic role. DATA SOURCES: A computerized search of the MEDLINE database was used to identify English ...
J A, Barone   +3 more
openaire   +2 more sources

Prokinetics in Patients with Gastroparesis: A Systematic Analysis

Digestion, 1999
<i>Background:</i> The relative potency of prokinetics in patients with gastroparesis has not been systematically studied. This study, therefore, aimed to assess the available data and to compare the effects of different prokinetics on symptoms and gastric emptying rates in patients with gastroparesis.
Sturm, Andreas   +3 more
openaire   +4 more sources

Erythromycin as a gastrointestinal prokinetic agent

Intensive and Critical Care Nursing, 2001
Erythromycin is a potent stimulator of gastrointestinal (GI) motility and can be a useful agent to treat GI stasis in patients who are critically ill. However, it is not licensed for this indication and has serious drug interactions which may limit its utility.
openaire   +2 more sources

PROKINETIC AGENTS IN POSTGASTRECTOMY PATIENTS

Gastroenterology Clinics of North America, 1994
Postgastrectomy syndromes are uncommon but, unfortunately, frustrating for both patient and physician, because treatment with prokinetic agents is often of limited benefit. This article examines the evidence for efficacy of available prokinetic drugs in the management of these difficult disorders.
openaire   +2 more sources

Gastroesophageal Reflux and Prokinetic Agents

Neonatal Network, 2005
GASTROESOPHAGEAL REFLUX (GER), a common problem in preterm and term infants, occurs when there is retrograde movement of gastric contents into the esophagus. The severity of the reflux is related to the height of the gastric contents up into the esophagus or the oral pharynx. Transient lower esophageal sphincter relaxation is the main mechanism thought
openaire   +2 more sources

Prokinetics and reflux: a promise unfulfilled

European Journal of Gastroenterology & Hepatology, 2002
Gastro-oesophageal reflux disease (GORD) has been described as a motility disorder of the upper gastrointestinal tract. Disturbances of lower oesophageal sphincter function, lower oesophageal body motility, oesophageal clearance and gastric emptying are well accepted.
openaire   +2 more sources

[Prokinetic drugs].

Nordisk medicin, 1992
Prokinetic drugs--preparations that stimulate gastro-intestinal motility--constitute a relatively new concept in medical therapy, chiefly represented by the products cisapride and metoclopramide. This review consists in an account of the physiological regulation of motility in the upper gastro-intestinal tract where prokinetic drugs are considered to ...
openaire   +1 more source

Choosing a Prokinetic

American Journal of Gastroenterology, 2020
openaire   +2 more sources

Home - About - Disclaimer - Privacy